Proteostasis Therapeutics Overview
Proteostasis Therapeutics (PTI) has a P/E ratio of 0.0, below the Healthcare sector average of 24.78.
Get informed when a big investor buys or sells
+ Follow0.00
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, PTI shows a P/E ratio of 0.0. That is below the Healthcare sector average of 24.78. Scroll down for historical charts and peer comparison views.
The Healthcare sector average P/E ratio is about 24.78. Proteostasis Therapeutics is at 0.0, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how PTI stacks up against individual peers as well.
Investors watch PTI's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Proteostasis Therapeutics's latest reading is 0.0. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Proteostasis Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 0.0) with ownership activity and broader fundamentals.
The Healthcare average P/E ratio is about 24.78, while PTI is at 0.0. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
